Atlas Trials

Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia

Clinical trial NCT06830733 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06830733
Sponsor
Fundacion Clinic per a la Recerca Biomédica
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia, Plasma Cell
Start date
2025-04-01
Primary completion
2025-12-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.